Dafiro HCT

· Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dafiro HCT, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: EMA Authorised: Dafiro HCT (valsartan;hydrochlorothiazide;amlodipine besilate) — Novartis Europharm Limited